Cargando…

Diagnostic and prognostic utility of mid-expiratory flow rate in older community-dwelling persons with respiratory symptoms, but without chronic obstructive pulmonary disease

BACKGROUND: The maximal expiratory flow at 50 % of the forced vital capacity (MEF(50)) is the flow where half of forced vital capacity (FVC) remains to be exhaled. A reduced MEF(50) has been suggested as a surrogate marker of small airways disease. The diagnostic and prognostic utility of this easy...

Descripción completa

Detalles Bibliográficos
Autores principales: Güder, Gülmisal, Brenner, Susanne, Störk, Stefan, Held, Matthias, Broekhuizen, Berna DL, Lammers, Jan-Willem J, Hoes, Arno W, Rutten, Frans H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4521503/
https://www.ncbi.nlm.nih.gov/pubmed/26228243
http://dx.doi.org/10.1186/s12890-015-0081-4
_version_ 1782383823112110080
author Güder, Gülmisal
Brenner, Susanne
Störk, Stefan
Held, Matthias
Broekhuizen, Berna DL
Lammers, Jan-Willem J
Hoes, Arno W
Rutten, Frans H
author_facet Güder, Gülmisal
Brenner, Susanne
Störk, Stefan
Held, Matthias
Broekhuizen, Berna DL
Lammers, Jan-Willem J
Hoes, Arno W
Rutten, Frans H
author_sort Güder, Gülmisal
collection PubMed
description BACKGROUND: The maximal expiratory flow at 50 % of the forced vital capacity (MEF(50)) is the flow where half of forced vital capacity (FVC) remains to be exhaled. A reduced MEF(50) has been suggested as a surrogate marker of small airways disease. The diagnostic and prognostic utility of this easy to assess spirometric variable in persons with respiratory symptoms, but without COPD is unclear. METHODS: We used data from the UHFO-COPD cohort in which 405 community-dwelling persons aged 65 years or over, and a general practitioner’s diagnosis of chronic obstructive pulmonary disease (COPD) underwent pulmonary function testing and echocardiography. In total 161 patients had no COPD according to the spirometric GOLD criteria. We considered MEF(50) as reduced if < 60 % of predicted. RESULTS: Of the 161 patients without COPD (mean age 72 ± 5.7 years; 35 % male; follow-up 4.5 ± 1.1 years), 61 (37.9 %) had a reduced MEF(50). They were older, had more pack-years of smoking, more respiratory symptoms, and used more frequently inhaled medication than the remaining 100 subjects. A reduced MEF(50) was nearly twice as often associated with newly detected heart failure (HF) at assessment (29.5 % vs. 15.6 %, p = 0.045). In age-and sex-adjusted Cox regression analysis, a reduced MEF(50) was significantly associated with episodes of acute bronchitis (hazard ratio 2.54 95 % confidence interval (1.26; 5.13) P = 0.009), and in trend with pneumonia (2.14 (0.98; 4.69) P = 0.06) and hospitalizations for pulmonary reasons (2.28 (0.93; 5.62) P = 0.07). CONCLUSIONS: In older community-dwelling persons with pulmonary symptoms but without COPD, a reduced MEF(50) may help to uncover unrecognized HF, and identify those at a higher risk for episodes of acute bronchitis, pneumonia and hospitalizations for pulmonary reasons. Echocardiography and close follow-up should be considered in these patients.
format Online
Article
Text
id pubmed-4521503
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-45215032015-08-01 Diagnostic and prognostic utility of mid-expiratory flow rate in older community-dwelling persons with respiratory symptoms, but without chronic obstructive pulmonary disease Güder, Gülmisal Brenner, Susanne Störk, Stefan Held, Matthias Broekhuizen, Berna DL Lammers, Jan-Willem J Hoes, Arno W Rutten, Frans H BMC Pulm Med Research Article BACKGROUND: The maximal expiratory flow at 50 % of the forced vital capacity (MEF(50)) is the flow where half of forced vital capacity (FVC) remains to be exhaled. A reduced MEF(50) has been suggested as a surrogate marker of small airways disease. The diagnostic and prognostic utility of this easy to assess spirometric variable in persons with respiratory symptoms, but without COPD is unclear. METHODS: We used data from the UHFO-COPD cohort in which 405 community-dwelling persons aged 65 years or over, and a general practitioner’s diagnosis of chronic obstructive pulmonary disease (COPD) underwent pulmonary function testing and echocardiography. In total 161 patients had no COPD according to the spirometric GOLD criteria. We considered MEF(50) as reduced if < 60 % of predicted. RESULTS: Of the 161 patients without COPD (mean age 72 ± 5.7 years; 35 % male; follow-up 4.5 ± 1.1 years), 61 (37.9 %) had a reduced MEF(50). They were older, had more pack-years of smoking, more respiratory symptoms, and used more frequently inhaled medication than the remaining 100 subjects. A reduced MEF(50) was nearly twice as often associated with newly detected heart failure (HF) at assessment (29.5 % vs. 15.6 %, p = 0.045). In age-and sex-adjusted Cox regression analysis, a reduced MEF(50) was significantly associated with episodes of acute bronchitis (hazard ratio 2.54 95 % confidence interval (1.26; 5.13) P = 0.009), and in trend with pneumonia (2.14 (0.98; 4.69) P = 0.06) and hospitalizations for pulmonary reasons (2.28 (0.93; 5.62) P = 0.07). CONCLUSIONS: In older community-dwelling persons with pulmonary symptoms but without COPD, a reduced MEF(50) may help to uncover unrecognized HF, and identify those at a higher risk for episodes of acute bronchitis, pneumonia and hospitalizations for pulmonary reasons. Echocardiography and close follow-up should be considered in these patients. BioMed Central 2015-07-31 /pmc/articles/PMC4521503/ /pubmed/26228243 http://dx.doi.org/10.1186/s12890-015-0081-4 Text en © Güder et al. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Güder, Gülmisal
Brenner, Susanne
Störk, Stefan
Held, Matthias
Broekhuizen, Berna DL
Lammers, Jan-Willem J
Hoes, Arno W
Rutten, Frans H
Diagnostic and prognostic utility of mid-expiratory flow rate in older community-dwelling persons with respiratory symptoms, but without chronic obstructive pulmonary disease
title Diagnostic and prognostic utility of mid-expiratory flow rate in older community-dwelling persons with respiratory symptoms, but without chronic obstructive pulmonary disease
title_full Diagnostic and prognostic utility of mid-expiratory flow rate in older community-dwelling persons with respiratory symptoms, but without chronic obstructive pulmonary disease
title_fullStr Diagnostic and prognostic utility of mid-expiratory flow rate in older community-dwelling persons with respiratory symptoms, but without chronic obstructive pulmonary disease
title_full_unstemmed Diagnostic and prognostic utility of mid-expiratory flow rate in older community-dwelling persons with respiratory symptoms, but without chronic obstructive pulmonary disease
title_short Diagnostic and prognostic utility of mid-expiratory flow rate in older community-dwelling persons with respiratory symptoms, but without chronic obstructive pulmonary disease
title_sort diagnostic and prognostic utility of mid-expiratory flow rate in older community-dwelling persons with respiratory symptoms, but without chronic obstructive pulmonary disease
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4521503/
https://www.ncbi.nlm.nih.gov/pubmed/26228243
http://dx.doi.org/10.1186/s12890-015-0081-4
work_keys_str_mv AT gudergulmisal diagnosticandprognosticutilityofmidexpiratoryflowrateinoldercommunitydwellingpersonswithrespiratorysymptomsbutwithoutchronicobstructivepulmonarydisease
AT brennersusanne diagnosticandprognosticutilityofmidexpiratoryflowrateinoldercommunitydwellingpersonswithrespiratorysymptomsbutwithoutchronicobstructivepulmonarydisease
AT storkstefan diagnosticandprognosticutilityofmidexpiratoryflowrateinoldercommunitydwellingpersonswithrespiratorysymptomsbutwithoutchronicobstructivepulmonarydisease
AT heldmatthias diagnosticandprognosticutilityofmidexpiratoryflowrateinoldercommunitydwellingpersonswithrespiratorysymptomsbutwithoutchronicobstructivepulmonarydisease
AT broekhuizenbernadl diagnosticandprognosticutilityofmidexpiratoryflowrateinoldercommunitydwellingpersonswithrespiratorysymptomsbutwithoutchronicobstructivepulmonarydisease
AT lammersjanwillemj diagnosticandprognosticutilityofmidexpiratoryflowrateinoldercommunitydwellingpersonswithrespiratorysymptomsbutwithoutchronicobstructivepulmonarydisease
AT hoesarnow diagnosticandprognosticutilityofmidexpiratoryflowrateinoldercommunitydwellingpersonswithrespiratorysymptomsbutwithoutchronicobstructivepulmonarydisease
AT ruttenfransh diagnosticandprognosticutilityofmidexpiratoryflowrateinoldercommunitydwellingpersonswithrespiratorysymptomsbutwithoutchronicobstructivepulmonarydisease